HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation - PubMed (original) (raw)
. 2004 Nov 1;104(9):2810-7.
doi: 10.1182/blood-2003-07-2314. Epub 2004 Jul 1.
Affiliations
- PMID: 15231570
- DOI: 10.1182/blood-2003-07-2314
Free article
HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation
Anna Smed-Sörensen et al. Blood. 2004.
Free article
Abstract
Dendritic cells (DCs) are antigen-presenting cells with the capacity to prime naive T cells for efficient cellular responses against pathogens such as HIV-1. DCs are also susceptible to HIV-1 infection, which may impair their ability to induce immunity. Here, we examined the ability of HIV-1-infected, in vitro-derived DCs to respond to CD40 ligand (CD40L) stimulation with the aim to study events during early HIV-1 infection. HIV-1(BaL)-infected p24(+) DCs were detected after only 3 days of exposure to highly concentrated virus. We show that HIV-1-infected DCs up-regulated costimulatory molecules, but were skewed in their production of effector cytokines in response to CD40L stimulation. CD40L stimulation induced significant secretion of tumor necrosis factor alpha (TNFalpha) and interleukin 12 (IL-12) p70 from both HIV-1-exposed and unexposed DCs. Intracellular stainings of HIV-1-exposed DCs revealed that TNFalpha could be detected in both the p24(-) and p24(+) DCs, but IL-12 p70 could be found only in the p24(-) DCs. Thus, although p24(+) DCs showed a mature phenotype similar to p24(-) DCs after CD40L stimulation, they appeared to have an impaired cytokine profile. These observations suggest that HIV-1 infection disables DC function, a phenomenon that may be relevant for optimal induction of HIV-1-specific immune responses.
Similar articles
- Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
Fan Z, Huang XL, Kalinski P, Young S, Rinaldo CR Jr. Fan Z, et al. Clin Vaccine Immunol. 2007 Sep;14(9):1127-37. doi: 10.1128/CVI.00141-07. Epub 2007 Jul 18. Clin Vaccine Immunol. 2007. PMID: 17634507 Free PMC article. - Quantities of interleukin-12p40 in mature CD8alpha negative dendritic cells correlate with strength of TCR signal and determine Th cell development.
Fujimoto N, Ishida H, Nakamura I, Ogasawara K, Itoh Y. Fujimoto N, et al. Microbiol Immunol. 2003;47(12):1017-24. doi: 10.1111/j.1348-0421.2003.tb03462.x. Microbiol Immunol. 2003. PMID: 14695452 - Dendritic cells in innate immune responses against HIV.
Servet C, Zitvogel L, Hosmalin A. Servet C, et al. Curr Mol Med. 2002 Dec;2(8):739-56. doi: 10.2174/1566524023361907. Curr Mol Med. 2002. PMID: 12462394 Review. - Virology- and immunology-based gene therapy for cancer.
Tagawa M, Kawamura K, Shimozato O, Ma G, Li Q, Suzuki N, Shimada H, Ochiai T. Tagawa M, et al. Cancer Immunol Immunother. 2006 Nov;55(11):1420-5. doi: 10.1007/s00262-006-0173-3. Epub 2006 May 12. Cancer Immunol Immunother. 2006. PMID: 16691360 Free PMC article. Review.
Cited by
- Mapping the interplay between NK cells and HIV: therapeutic implications.
Anderko RR, Mailliard RB. Anderko RR, et al. J Leukoc Biol. 2023 Feb 1;113(2):109-138. doi: 10.1093/jleuko/qiac007. J Leukoc Biol. 2023. PMID: 36822173 Free PMC article. Review. - MAVS Genetic Variation Is Associated with Decreased HIV-1 Replication In Vitro and Reduced CD4+ T Cell Infection in HIV-1-Infected Individuals.
Stunnenberg M, van Pul L, Sprokholt JK, van Dort KA, Gringhuis SI, Geijtenbeek TBH, Kootstra NA. Stunnenberg M, et al. Viruses. 2020 Jul 16;12(7):764. doi: 10.3390/v12070764. Viruses. 2020. PMID: 32708557 Free PMC article. - Manipulation of Mononuclear Phagocytes by HIV: Implications for Early Transmission Events.
Bertram KM, Tong O, Royle C, Turville SG, Nasr N, Cunningham AL, Harman AN. Bertram KM, et al. Front Immunol. 2019 Sep 24;10:2263. doi: 10.3389/fimmu.2019.02263. eCollection 2019. Front Immunol. 2019. PMID: 31616434 Free PMC article. Review. - Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.
Saxena M, Sabado RL, La Mar M, Mohri H, Salazar AM, Dong H, Correa Da Rosa J, Markowitz M, Bhardwaj N, Miller E. Saxena M, et al. Front Immunol. 2019 Apr 9;10:725. doi: 10.3389/fimmu.2019.00725. eCollection 2019. Front Immunol. 2019. PMID: 31024557 Free PMC article. Clinical Trial. - Dendritic Cell Response to HIV-1 Is Controlled by Differentiation Programs in the Cells and Strain-Specific Properties of the Virus.
Nasi A, Amu S, Göthlin M, Jansson M, Nagy N, Chiodi F, Réthi B. Nasi A, et al. Front Immunol. 2017 Mar 13;8:244. doi: 10.3389/fimmu.2017.00244. eCollection 2017. Front Immunol. 2017. PMID: 28348557 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials